BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29336640)

  • 21. Bi-allelic
    Rasheed A; Gumus E; Zaki M; Johnson K; Manzoor H; LaForce G; Ross D; McEvoy-Venneri J; Stanley V; Lee S; Virani A; Ben-Omran T; Gleeson JG; Naz S; Schaffer A
    J Med Genet; 2021 Apr; 58(4):237-246. PubMed ID: 32439809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy.
    Kettwig M; Ternka K; Wendland K; Krüger DM; Zampar S; Schob C; Franz J; Aich A; Winkler A; Sakib MS; Kaurani L; Epple R; Werner HB; Hakroush S; Kitz J; Prinz M; Bartok E; Hartmann G; Schröder S; Rehling P; Henneke M; Boretius S; Alia A; Wirths O; Fischer A; Stadelmann C; Nessler S; Gärtner J
    Nat Commun; 2021 Nov; 12(1):6530. PubMed ID: 34764281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation.
    Yang S; Wu L; Liao H; Lu X; Zhang X; Kuang X; Yang L
    Neurogenetics; 2021 Oct; 22(4):323-332. PubMed ID: 34370157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular trafficking of RNASET2, a novel component of P-bodies.
    Vidalino L; Monti L; Haase A; Moro A; Acquati F; Taramelli R; Macchi P
    Biol Cell; 2012 Jan; 104(1):13-21. PubMed ID: 22188480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
    DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
    J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The failure of microglia to digest developmental apoptotic cells contributes to the pathology of RNASET2-deficient leukoencephalopathy.
    Hamilton N; Rutherford HA; Petts JJ; Isles HM; Weber T; Henneke M; Gärtner J; Dunning MJ; Renshaw SA
    Glia; 2020 Jul; 68(7):1531-1545. PubMed ID: 32212285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-phenotype correlation of congenital anomalies in multiple congenital anomalies hypotonia seizures syndrome (MCAHS1)/PIGN-related epilepsy.
    Fleming L; Lemmon M; Beck N; Johnson M; Mu W; Murdock D; Bodurtha J; Hoover-Fong J; Cohn R; Bosemani T; Barañano K; Hamosh A
    Am J Med Genet A; 2016 Jan; 170A(1):77-86. PubMed ID: 26394714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNASET2 as a tumor antagonizing gene in a melanoma cancer model.
    Monti L; Rodolfo M; Lo Russo G; Noonan D; Acquati F; Taramelli R
    Oncol Res; 2008; 17(2):69-74. PubMed ID: 18543608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Strategies for Expression and Purification of Recombinant Human RNASET2 Protein in Pichia pastoris.
    Lualdi M; Pedrini E; Petroni F; Näsman J; Lindqvist C; Scaldaferri D; Taramelli R; Inforzato A; Acquati F
    Mol Biotechnol; 2015 Jun; 57(6):513-25. PubMed ID: 25663099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
    Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
    Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SATB2-associated syndrome presenting with Rett-like phenotypes.
    Lee JS; Yoo Y; Lim BC; Kim KJ; Choi M; Chae JH
    Clin Genet; 2016 Jun; 89(6):728-32. PubMed ID: 26596517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia.
    Khan K; Zech M; Morgan AT; Amor DJ; Skorvanek M; Khan TN; Hildebrand MS; Jackson VE; Scerri TS; Coleman M; Rigbye KA; Scheffer IE; Bahlo M; Wagner M; Lam DD; Berutti R; Havránková P; Fečíková A; Strom TM; Han V; Dosekova P; Gdovinova Z; Laccone F; Jameel M; Mooney MR; Baig SM; Jech R; Davis EE; Katsanis N; Winkelmann J
    Genet Med; 2019 Nov; 21(11):2532-2542. PubMed ID: 31036918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel FBXO28 frameshift mutation in a child with developmental delay, dysmorphic features, and intractable epilepsy: A second gene that may contribute to the 1q41-q42 deletion phenotype.
    Balak C; Belnap N; Ramsey K; Joss S; Devriendt K; Naymik M; Jepsen W; Siniard AL; Szelinger S; Parker ME; Richholt R; Izatt T; LaFleur M; Terraf P; Llaci L; De Both M; Piras IS; Rangasamy S; Schrauwen I; Craig DW; Huentelman M; Narayanan V
    Am J Med Genet A; 2018 Jul; 176(7):1549-1558. PubMed ID: 30160831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the phenotypic spectrum associated with OPHN1 variants.
    Schwartz TS; Wojcik MH; Pelletier RC; Edward HL; Picker JD; Holm IA; Towne MC; Beggs AH; Agrawal PB
    Eur J Med Genet; 2019 Feb; 62(2):137-143. PubMed ID: 29960046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. West syndrome, developmental and epileptic encephalopathy, and severe CNS disorder associated with WWOX mutations.
    Shaukat Q; Hertecant J; El-Hattab AW; Ali BR; Suleiman J
    Epileptic Disord; 2018 Oct; 20(5):401-412. PubMed ID: 30361190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic expansion in Zhu-Tokita-Takenouchi-Kim syndrome caused by de novo variants in the SON gene.
    Slezak R; Smigiel R; Rydzanicz M; Pollak A; Kosinska J; Stawinski P; Malgorzata Sasiadek M; Ploski R
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1432. PubMed ID: 32705777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNASET2, GPR174, and PTPN22 gene polymorphisms are related to the risk of liver damage associated with the hyperthyroidism in patients with Graves' disease.
    Zhang Q; Liu S; Guan Y; Chen Q; Zhang Q; Min X
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28568286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic variants in
    Granadillo JL; P A Stegmann A; Guo H; Xia K; Angle B; Bontempo K; Ranells JD; Newkirk P; Costin C; Viront J; Stumpel CT; Sinnema M; Panis B; Pfundt R; Krapels IPC; Klaassens M; Nicolai J; Li J; Jiang Y; Marco E; Canton A; Latronico AC; Montenegro L; Leheup B; Bonnet C; M Amudhavalli S; Lawson CE; McWalter K; Telegrafi A; Pearson R; Kvarnung M; Wang X; Bi W; Rosenfeld JA; Shinawi M
    J Med Genet; 2020 Oct; 57(10):717-724. PubMed ID: 32152250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular and phenotypic spectrum of CLCN4-related epilepsy.
    He H; Guzman RE; Cao D; Sierra-Marquez J; Yin F; Fahlke C; Peng J; Stauber T
    Epilepsia; 2021 Jun; 62(6):1401-1415. PubMed ID: 33951195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.